Literature DB >> 17147699

Drug reward and intake in lines of mice selectively bred for divergent exploration of a hole board apparatus.

C L Kliethermes1, H M Kamens, J C Crabbe.   

Abstract

Individuals characterized as high-novelty seekers are more likely to abuse drugs than are low-novelty seekers, and it is possible that the biological substrates underlying novelty seeking and drug abuse are similar. We selectively bred replicate lines of mice from a B6D2 F3 hybrid stock for high exploratory behavior (HEB) or low exploratory behavior (LEB) as measured by the number of head dips on a hole board. To determine whether common genes might influence exploratory behavior and behaviors relevant to drug abuse, we tested HEB and LEB mice for conditioned place preference produced by ethanol and d-amphetamine and also examined oral methamphetamine intake. After four generations of selection, HEB and LEB mice did not differ in the magnitude of place preference for ethanol, but LEB mice showed a greater place preference for an amphetamine-paired location than did HEB mice. However, this difference did not replicate in mice tested from the fifth generation of selection. The selected lines also did not differ in sensitization to the locomotor stimulant effects of d-amphetamine that developed across the conditioning trials. Finally, HEB and LEB mice consumed equivalently low amounts of methamphetamine. These results suggest that common genes do not influence head dipping and several behaviors potentially relevant to drug abuse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17147699     DOI: 10.1111/j.1601-183X.2006.00289.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  8 in total

Review 1.  Individual differences and social influences on the neurobehavioral pharmacology of abused drugs.

Authors:  M T Bardo; J L Neisewander; T H Kelly
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

2.  Genetics of novelty seeking, amphetamine self-administration and reinstatement using inbred rats.

Authors:  A C Meyer; S Rahman; R J Charnigo; L P Dwoskin; J C Crabbe; M T Bardo
Journal:  Genes Brain Behav       Date:  2010-08-16       Impact factor: 3.449

3.  Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence.

Authors:  A Mateos-García; C Roger-Sánchez; M Rodriguez-Arias; J Miñarro; M A Aguilar; C Manzanedo; M C Arenas
Journal:  Psychopharmacology (Berl)       Date:  2014-06-08       Impact factor: 4.530

4.  Association of novelty-related behaviors and intravenous cocaine self-administration in Diversity Outbred mice.

Authors:  Price E Dickson; Juliet Ndukum; Troy Wilcox; James Clark; Brittany Roy; Lifeng Zhang; Yun Li; Da-Ting Lin; Elissa J Chesler
Journal:  Psychopharmacology (Berl)       Date:  2014-09-20       Impact factor: 4.530

5.  Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.

Authors:  Wei Hu; Tina Lu; Alan Chen; Ying Huang; Rolf Hansen; L Judson Chandler; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2011-04-21       Impact factor: 4.530

Review 6.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

7.  The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence.

Authors:  Sandra Montagud-Romero; Manuel Daza-Losada; Antonio Vidal-Infer; Concepción Maldonado; María A Aguilar; Jose Miñarro; Marta Rodríguez-Arias
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 8.  Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models.

Authors:  M Carmen Arenas; María A Aguilar; Sandra Montagud-Romero; Ana Mateos-García; Concepción I Navarro-Francés; José Miñarro; Marta Rodríguez-Arias
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.